Rw. Day et al., A RANDOMIZED, CONTROLLED-STUDY OF THE 1-HOUR AND 24-HOUR EFFECTS OF INHALED NITRIC-OXIDE THERAPY IN CHILDREN WITH ACUTE HYPOXEMIC RESPIRATORY-FAILURE, Chest, 112(5), 1997, pp. 1324-1331
Study objective: To determine whether 24 h of inhaled nitric oxide imp
roves oxygenation greater than conventional therapy alone in children
with acute hypoxemic respiratory failure, Design: Prospective, randomi
zed, controlled study, Setting: Twenty-six-bed pediatric ICU in a tert
iary children's hospital. Patients: Twenty-four patients with acute bi
lateral lung disease requiring a positive-end expiratory pressure > 6
cm H2O and a fraction of inspired oxygen > 0.5 for > 12 h. Interventio
ns: Twelve patients were treated with 10 ppm inhaled nitric oxide from
the onset of randomization and 12 control patients were initially mai
ntained on a regimen of conventional therapy alone. After a period of
24 h, control patients were also treated with 10 ppm inhaled nitric ox
ide. Hemodynamic and blood gas measurements were performed at baseline
, at 1 h after randomization, and at 24-h intervals for 2 days. Measur
ements and results: Inhaled nitric oxide decreased the ratio of pulmon
ary to systemic vascular resistance and improved oxygenation indexes d
uring the initial hour following randomization, However, 24 h after ra
ndomization, the oxygenation indexes of 11 surviving treated patients
were not improved in comparison to baseline or the oxygenation indexes
of 10 surviving control patients, Oxygenation indexes acutely improve
d in control patients when inhaled nitric oxide was started after 24 h
of conventional therapy, Oxygenation indexes remained improved in the
initial control patients after 24 h of inhaled nitric oxide, Conclusi
ons: Pulmonary vascular resistance and systemic oxygenation are acutel
y improved by 10 ppm inhaled nitric oxide in some children with severe
lung disease. However, a sustained improvement in oxygenation may not
occur during prolonged therapy, Thus, inhaled nitric oxide may have a
limited therapeutic role in children with acute hypoxemic respiratory
failure.